Strategic Partnerships Leverage RedShiftBio’s HaLCon bioprocess analytics platform and Aurora/Apollo systems to target CDMOs and biopharma manufacturers seeking integrated bioprocess analytics and high-sensitivity molecular structure measurement.

RNA and Protein Growth Capitalize on recent product launches like Aurora TX and the focus on RNA and protein analysis to pursue opportunities with research labs and biopharma companies advancing mRNA therapies, monoclonals, and complex biologics.

Quality and Compliance Position the technology as a means to monitor critical quality attributes with ultra-precise measurements, appealing to manufacturers needing rigorous characterization to ensure safety, efficacy, and stability.

Global Field Support Highlight the wide sales, applications, and service network, plus demonstrations at partner sites, to address global customers seeking reliable access to expert support and rapid onboarding.

Strategic Investors Leverage backing from Waters, Illumina Ventures, and others to validate credibility with potential customers and persuade procurement teams about long-term viability and ecosystem integration.